Opportunities for Biosimilars: A Multidisciplinary Perspective
Experts discuss the transition from biologics to biosimilars and emphasize the importance of adaptability when non-medical switching occurs.
Understanding and Improving Access of Biosimilars in Oncology
Stakeholders Summit: Provider Education on Biosimilars
Bringing Oncology Biosimilars to Patients
Regulation, Policy, and Litigation in Biosimilars
Clinical Advances and Challenges With Biosimilars
Clinician and Managed Care Insights on Biosimilars for Inflammatory Diseases
